Beyond Genome-Wide Scans: Advancing Hypertension Genomics Into the Future

This publication has 10 references indexed in Scilit:

• Affinity-optimizing enhancer variants disrupt development
  Nature, 2024
• Integration of genetic fine-mapping and multi-omics data reveals candidate effector genes for hypertension
  The American Journal of Human Genetics, 2023
• Principles and methods for transferring polygenic risk scores across global populations
  Nature Reviews Genetics, 2023
• Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension
  New England Journal of Medicine, 2023
• Effect of Vupanorsen on Non–High-Density Lipoprotein Cholesterol Levels in Statin-Treated Patients With Elevated Cholesterol: TRANSLATE-TIMI 70
  Circulation, 2022
• Exome sequencing and analysis of 454,787 UK Biobank participants
  Nature, 2021
• CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
  New England Journal of Medicine, 2021
• Genomics of hypertension: the road to precision medicine
  Nature Reviews Cardiology, 2020
• The road ahead in genetics and genomics
  Nature Reviews Genetics, 2020
• Induced pluripotent stem cells in disease modelling and drug discovery
  Nature Reviews Genetics, 2019